ASRT vs COP · rev $125.0M vs P/E 19, rev $58.94B
Assertio Therapeutics Inc (ASRT) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
ASRT currently screens at market cap $151.5M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the ASRT and COP stock pages for the full models.
Not investment advice.